Published in Gut on December 03, 2010
IgG4-related autoimmune diseases: Polymorphous presentation complicates diagnosis and treatment. Dtsch Arztebl Int (2015) 1.70
Endoscopic retrograde cholangiography does not reliably distinguish IgG4-associated cholangitis from primary sclerosing cholangitis or cholangiocarcinoma. Clin Gastroenterol Hepatol (2011) 1.14
Type 1 autoimmune pancreatitis. Orphanet J Rare Dis (2011) 1.10
Role of diagnostic and therapeutic endoscopic ultrasonography in benign pancreatic diseases. Endosc Ultrasound (2013) 0.91
Autoimmune Pancreatitis: A Multiorgan Disease Presenting a Conundrum for Clinicians in the West. Gastroenterol Hepatol (N Y) (2015) 0.87
Chronic pancreatitis. Curr Opin Gastroenterol (2012) 0.83
Reduction of splenic volume by steroid therapy in cases with autoimmune pancreatitis. J Gastroenterol (2012) 0.83
IgG4-related disease: a new kid on the block or an old aquaintance? United European Gastroenterol J (2014) 0.83
Endoscopic retrograde pancreatography: When should we do it? World J Gastrointest Endosc (2015) 0.79
Serum trypsin and TCR as novel markers for predicting disease activity in IgG4-related disease. Cent Eur J Immunol (2014) 0.77
Characteristic findings of endoscopic retrograde cholangiopancreatography in autoimmune pancreatitis. Gut Liver (2015) 0.77
Diagnostic endoscopic retrograde pancreatography for autoimmune pancreatitis: one size does not fit all. Gastroenterology (2011) 0.76
Autoimmune pancreatitis in the context of IgG4-related disease: review of imaging findings. World J Gastroenterol (2014) 0.76
Autoimmune Pancreatitis. Gastroenterol Rep (2013) 0.75
The benefits of diagnostic ERCP in autoimmune pancreatitis. Gut (2011) 0.75
From Pathogenesis, Clinical Manifestation, and Diagnosis to Treatment: An Overview on Autoimmune Pancreatitis. Gastroenterol Res Pract (2017) 0.75
Autoimmune pancreatitis. Gland Surg (2016) 0.75
[Hepatopancreaticobiliary diseases in IgG4-associated autoimmune diseases]. Radiologe (2016) 0.75
The B73 maize genome: complexity, diversity, and dynamics. Science (2009) 18.73
Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med (2010) 15.71
Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut (2012) 10.56
Guideline for the management of ingested foreign bodies. Gastrointest Endosc (2002) 9.03
Consensus statement on the pathology of IgG4-related disease. Mod Pathol (2012) 9.01
Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol (2012) 7.39
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology (2007) 6.68
Quality indicators for colonoscopy. Am J Gastroenterol (2006) 6.51
A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol (2003) 6.04
American College of Gastroenterology guideline: management of acute pancreatitis. Am J Gastroenterol (2013) 5.96
Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology (2010) 5.00
Diagnosis of autoimmune pancreatitis: the Mayo Clinic experience. Clin Gastroenterol Hepatol (2006) 4.70
International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas (2011) 4.56
Factors predictive of adverse events following endoscopic papillary large balloon dilation: results from a multicenter series. Dig Dis Sci (2012) 4.35
Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology (2007) 4.33
A consensus document on bowel preparation before colonoscopy: prepared by a task force from the American Society of Colon and Rectal Surgeons (ASCRS), the American Society for Gastrointestinal Endoscopy (ASGE), and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES). Gastrointest Endosc (2006) 4.31
Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum (2012) 4.27
A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc (2010) 4.26
A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol (2011) 4.26
The use of rapid indicators for the detection of organic residues on clinically used gastrointestinal endoscopes with and without visually apparent debris. Infect Control Hosp Epidemiol (2014) 3.96
IgG4-related sclerosing disease. World J Gastroenterol (2008) 3.84
Quality indicators for colonoscopy. Gastrointest Endosc (2006) 3.83
Self-expanding plastic stents in treatment of benign esophageal conditions. Gastrointest Endosc (2007) 3.59
Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol (2002) 3.41
Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology (2004) 3.25
Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis. Gastroenterology (2010) 3.24
ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc (2006) 3.12
Endoscopic ultrasonography-guided ethanol lavage with paclitaxel injection treats patients with pancreatic cysts. Gastroenterology (2010) 3.11
Clinical diagnostic criteria of autoimmune pancreatitis: revised proposal. J Gastroenterol (2006) 3.04
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol (2009) 2.92
Rectal nonsteroidal anti-inflammatory drugs are superior to pancreatic duct stents in preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a network meta-analysis. Clin Gastroenterol Hepatol (2013) 2.91
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update. Gut (2012) 2.91
Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology (2002) 2.76
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis. Hepatology (2009) 2.75
Sedation and anesthesia in GI endoscopy. Gastrointest Endosc (2008) 2.73
Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer. Am J Gastroenterol (2007) 2.73
Frequent detection of pancreatic lesions in asymptomatic high-risk individuals. Gastroenterology (2012) 2.69
ASGE guideline: colorectal cancer screening and surveillance. Gastrointest Endosc (2006) 2.63
Direct ex vivo analysis of hepatitis B virus-specific CD8(+) T cells associated with the control of infection. Gastroenterology (1999) 2.62
EUS-guided FNA of regional lymph nodes in patients with unresectable hilar cholangiocarcinoma. Gastrointest Endosc (2007) 2.61
Guidelines for antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc (2003) 2.60
Establishing a true assessment of endoscopic competence in ERCP during training and beyond: a single-operator learning curve for deep biliary cannulation in patients with native papillary anatomy. Gastrointest Endosc (2007) 2.60
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology (2008) 2.58
Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis. Hepatology (2010) 2.55
Autoimmune chronic pancreatitis. Am J Gastroenterol (2004) 2.53
Endoscopic placement of self-expandable metal stents for malignant colonic obstruction: long-term outcomes and complication factors. Gastrointest Endosc (2010) 2.52
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis. Gut (2012) 2.52
Retracted Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy. J Clin Oncol (2010) 2.49
Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma. Hepatology (2007) 2.42
A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc (2010) 2.38
Small (<4 cm) renal mass: differentiation of angiomyolipoma without visible fat from renal cell carcinoma utilizing MR imaging. Radiology (2012) 2.35
Impact of lymph node staging on therapy of esophageal carcinoma. Gastroenterology (2003) 2.35